Shanghai HeartCare Medical Technology Corporation Ltd. has issued a positive profit alert indicating a significant financial turnaround for the first half of 2025. The company anticipates a net profit of at least RMB40 million for the six months ending June 30, 2025. This marks a substantial improvement from a net loss of approximately RMB5.1 million during the same period in 2024. The improved financial performance is attributed to business growth leading to increased revenue and a reduction in the overall expense ratio. Additionally, the company has proposed utilizing its capital reserve to offset previous losses, further strengthening its financial position. Shareholders and potential investors are advised to consider this information cautiously when dealing with company securities.